Onkos to acquire Stryker/Stanmore’s Juvenile Tumor System

By

Back in 2016, Stryker acquired Stanmore Implants for $52M - read here

Onkos Surgical to acquire Stryker’s Juvenile Tumour System (MassDevice)
Onkos Surgical announced today that it agreed to acquire the Juvenile Tumour System (JTS) from Stryker (NYSE:SYK).
Parsippany, New Jersey–based Onkos entered into a definitive agreement with the orthopedic technology giant over the system designed to enable limb stabilization and growth in pediatric patients affected by bone cancers, severe arthropathy, severe trauma, revisions, oncology and malignant diseases.

The financial terms o...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.